Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Fabienne Maibach, Hassan Sadozai, S. Morteza Seyed Jafari, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 6, pp. 345-362
Closed Access | Times Cited: 1046
Ovarian Cancer Immunotherapy and Personalized Medicine
Susan Morand, Monika Devanaboyina, Hannah Staats, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6532-6532
Open Access | Times Cited: 243
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 237
The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution
Ajit J. Nirmal, Zoltan Maliga, Tuulia Vallius, et al.
Cancer Discovery (2022) Vol. 12, Iss. 6, pp. 1518-1541
Open Access | Times Cited: 158
Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 124
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He, Xinxin Xiong, Han Yang, et al.
Cell Research (2022) Vol. 32, Iss. 6, pp. 530-542
Open Access | Times Cited: 113
The Human Microbiota and Skin Cancer
Yu Ri Woo, Sang Hyun Cho, Jeong Deuk Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1813-1813
Open Access | Times Cited: 80
Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
Xiaoyan Sun, Weiran Liu, Leina Sun, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005531-e005531
Open Access | Times Cited: 70
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment
Markus Haake, Beatrice Haack, Tina Schäfer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
Yuyuan Zhang, Mengjun Xu, Yuqing Ren, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8 + T cell clone size and cytotoxicity
Robert Watson, Orion Tong, Rosalin Cooper, et al.
Science Immunology (2021) Vol. 6, Iss. 64
Open Access | Times Cited: 60
Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
Dan Liu, Xue Yang, Xiong-Zhi Wu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration
Franziska Werner, Christine Wagner, Martín Simón, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials
Dhananjay Yadav, Minseok Kwak, Pallavi Chauhan, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 909-922
Closed Access | Times Cited: 45
Role of miRNA in Melanoma Development and Progression
Agata Poniewierska-Baran, Sylwia Słuczanowska-Głąbowska, Paulina Małkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 201-201
Open Access | Times Cited: 38
Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures
Khoa Tran, Venkateswar Addala, Rebecca L. Johnston, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases
Eftychia Chatziioannou, Jana Roßner, Thazin New Aung, et al.
EBioMedicine (2023) Vol. 93, pp. 104644-104644
Open Access | Times Cited: 23
Artificial intelligence in digital histopathology for predicting patient prognosis and treatment efficacy in breast cancer
Christine McCaffrey, Chowdhury Arif Jahangir, Clodagh Murphy, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 5, pp. 363-377
Open Access | Times Cited: 8
The Dutch Early-Stage Melanoma (D-ESMEL) study: a discovery set and validation cohort to predict the absolute risk of distant metastases in stage I/II cutaneous melanoma
Catherine Zhou, Antien L. Mooyaart, Thamila Kerkour, et al.
European Journal of Epidemiology (2025)
Open Access | Times Cited: 1
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Daniela Esposito, Fabiana Napolitano, Daniela Claudia Maresca, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010421-e010421
Open Access | Times Cited: 1
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
Ikko Mito, Hideyuki Takahashi, Reika Kawabata‐Iwakawa, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 41
Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment
Xiaoyong Zheng, Yajie Ma, Yan Bai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Proteomics approaches to characterize the immune responses in cancer
Víctor Urbiola-Salvador, Dominika Miroszewska, Agnieszka Jabłońska, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 8, pp. 119266-119266
Open Access | Times Cited: 32
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
Yuru Chen, Jiazheng Sun, Yachan Luo, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top